Jing Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jing Yang has a total of 123 co-authors. Here are the top co-authors by number of shared publications:
- Lei Zhang
Department of Bioengineering School of Synthetic Biology and Biomanufacturing State Key Laboratory of Synthetic Biology Frontier Science Center for Synthetic Biology Tianjin University Tianjin China
35 shared publications Shu Tian
Department of Bioengineering School of Synthetic Biology and Biomanufacturing State Key Laboratory of Synthetic Biology Frontier Science Center for Synthetic Biology Tianjin University Tianjin China
17 shared publicationsQingsi Li
Department of Bioengineering School of Synthetic Biology and Biomanufacturing State Key Laboratory of Synthetic Biology Frontier Science Center for Synthetic Biology Tianjin University Tianjin China
15 shared publicationsSijia Xu
Department of Biochemical Engineering, School of Chemical Engineering and Technology, Frontier Science Center for Synthetic Biology (MOE)
11 shared publicationsXiangyu Zhang
Department of Bioengineering School of Synthetic Biology and Biomanufacturing State Key Laboratory of Synthetic Biology and Frontier Science Center for Synthetic Biology Tianjin University Tianjin China
11 shared publicationsXinmeng Liu
Department of Biochemical Engineering, School of Chemical Engineering and Technology, Frontier Science Center for Synthetic Biology (MOE)
10 shared publications
Latest Publications
- Open Access
- 22 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (19) , 8442
Correction: Gao et al. Dimethyl Sulfoxide-Free Cryopreservation of Human Umbilical Cord Mesenchymal Stem Cells Based on Zwitterionic Betaine and Electroporation. Int. J. Mol. Sci. 2021, 22, 7445
- 22 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (19) , 8442
Open AccessCorrection: Gao et al. Dimethyl Sulfoxide-Free Cryopreservation of Human Umbilical Cord Mesenchymal Stem Cells Based on Zwitterionic Betaine and Electroporation. Int. J. Mol. Sci. 2021, 22, 7445
- 17 May 2026
- Published by Wiley in Advanced Materials
- p. e73293
Development and Applications of Antifreeze Materials: From Nature to Design
Ice formation poses significant challenges across multiple domains, including biomedicine, food industry, infrastructure, and intelligent sensors, where freezing environments can cause serious functional and safety issues. The development of effective antifreeze materials has become an urgent priority. Nature offers valuable insights in this regard, having evolved diverse psychrotolerant organisms from microorganisms to plants and fish. Within these organisms, key small molecules and macromolecules responsible for cold tolerance have been progressively identified. Inspired by them, recent years have witnessed the design and synthesis of a series of high‐performance antifreeze materials through biomanufacturing or chemical synthesis. This review highlights the significant progress in antifreeze materials, tracing their evolution from natural models to rational design systems: (1) natural antifreeze materials and their mechanistic insights, with emphasis on molecular lessons for ice inhibition; (2) biomanufacturing and rational design of antifreeze proteins based on emerging structure‐activity relationships; (3) nature‐inspired synthetic antifreeze materials, such as polymers, hydrogels, and elastomers; and (4) key applications in cryopreservation, food preservation, anti‐icing coatings, and freezing‐tolerant flexible sensors. While promising advances have been made, this review also addresses persistent challenges in translating these laboratory innovations into scalable applications.
- 17 May 2026
- Published by Wiley in Advanced Materials
- p. e73293
Development and Applications of Antifreeze Materials: From Nature to Design
Ice formation poses significant challenges across multiple domains, including biomedicine, food industry, infrastructure, and intelligent sensors, where freezing environments can cause serious functional and safety issues. The development of effective antifreeze materials has become an urgent priority. Nature offers valuable insights in this regard, having evolved diverse psychrotolerant organisms from microorganisms to plants and fish. Within these organisms, key small molecules and macromolecules responsible for cold tolerance have been progressively identified. Inspired by them, recent years have witnessed the design and synthesis of a series of high‐performance antifreeze materials through biomanufacturing or chemical synthesis. This review highlights the significant progress in antifreeze materials, tracing their evolution from natural models to rational design systems: (1) natural antifreeze materials and their mechanistic insights, with emphasis on molecular lessons for ice inhibition; (2) biomanufacturing and rational design of antifreeze proteins based on emerging structure‐activity relationships; (3) nature‐inspired synthetic antifreeze materials, such as polymers, hydrogels, and elastomers; and (4) key applications in cryopreservation, food preservation, anti‐icing coatings, and freezing‐tolerant flexible sensors. While promising advances have been made, this review also addresses persistent challenges in translating these laboratory innovations into scalable applications.
Charge‐Tuning Ice Inhibition in Antifreeze Peptides
Antifreeze peptides (AFPTs) have garnered significant interest as promising ice growth inhibitors. However, the rational design of AFPTs is hindered by the unclear functional roles of non‐ice‐binding sites (NIBSs), especially whether the charge‐specific effect on ice inhibition exists. Here, we design a series of charged AFPTs and clarify the hidden contributions of the “dark matter” NIBSs, revealing their essential charge impact on the cryoprotective performance. Moderate net negative charges of NIBSs create a hydration‐mediated interfacial environment that facilitates AFPT adsorption onto ice crystals and enhances ice growth inhibition. However, excessive negative charges induce overly strong hydration layers that hinder effective interfacial contact and reduce solution pH, thereby leading to cytotoxicity. Positive charges promote ordered water arrangements conducive to ice growth. The optimal charged AFPT (a net charge of ‐2) exhibits a 3.5‐fold ice growth inhibition rate compared with other AFPTs, as well as possessing biocompatibility, thus enhancing the post‐thaw red blood cells recovery rate to above 93%. This work offers new insights on elucidating the structure‐activity relationship of AFPTs and provides a promising approach for developing a next‐generation cryoprotectant in clinical applications.
Charge‐Tuning Ice Inhibition in Antifreeze Peptides
Antifreeze peptides (AFPTs) have garnered significant interest as promising ice growth inhibitors. However, the rational design of AFPTs is hindered by the unclear functional roles of non‐ice‐binding sites (NIBSs), especially whether the charge‐specific effect on ice inhibition exists. Here, we design a series of charged AFPTs and clarify the hidden contributions of the “dark matter” NIBSs, revealing their essential charge impact on the cryoprotective performance. Moderate net negative charges of NIBSs create a hydration‐mediated interfacial environment that facilitates AFPT adsorption onto ice crystals and enhances ice growth inhibition. However, excessive negative charges induce overly strong hydration layers that hinder effective interfacial contact and reduce solution pH, thereby leading to cytotoxicity. Positive charges promote ordered water arrangements conducive to ice growth. The optimal charged AFPT (a net charge of ‐2) exhibits a 3.5‐fold ice growth inhibition rate compared with other AFPTs, as well as possessing biocompatibility, thus enhancing the post‐thaw red blood cells recovery rate to above 93%. This work offers new insights on elucidating the structure‐activity relationship of AFPTs and provides a promising approach for developing a next‐generation cryoprotectant in clinical applications.
Zwitterionic Self‐Constraining Lubricant Coating for Prevention of Dust‐Induced Icing
Anti‐icing coatings have gained significant attention to prevent ice accretion on infrastructure surfaces, particularly in aviation, power, and transportation sectors, owing to their energy‐saving and satisfactory anti‐icing performance. However, dust accumulation on anti‐icing coating surfaces significantly weakens their protective performance. Dust particulates adsorbed on the coating surfaces via electrostatic interaction is challenging to remove by wind power or rain washing alone. Herein, the dust‐induced icing process is clarified, and the process is effectively suppressed by a self‐constraining lubricant (SCL) coating based on ionic liquids (ILs) and zwitterionic copolymers. ILs (EMIES), embedded into the PDMS matrix, enhance the coating's conductivity (≈2.04 S/m) to dissipate surface static electricity and prevent the electrostatic adsorption of charged dust particles. The zwitterionic copolymer in SCL coating is designed to constrain ILs via electrostatic interaction and provide hydrophilic segments to enhance anti‐icing as well as deicing properties (heterogeneous ice nucleation temperature of −27.9°C, icing delay time of 1458 s, and ice adhesion strength of 8.1 kPa). This SCL coating presents dust‐repellent performance and retains excellent anti‐icing properties even when suffering from dust deposition. Meanwhile, it still maintained low ice adhesion strength after 30 icing‐deicing cycles. This work establishes a new dust‐repellent and anti‐icing strategy for outdoor infrastructure.
Zwitterionic Self‐Constraining Lubricant Coating for Prevention of Dust‐Induced Icing
Anti‐icing coatings have gained significant attention to prevent ice accretion on infrastructure surfaces, particularly in aviation, power, and transportation sectors, owing to their energy‐saving and satisfactory anti‐icing performance. However, dust accumulation on anti‐icing coating surfaces significantly weakens their protective performance. Dust particulates adsorbed on the coating surfaces via electrostatic interaction is challenging to remove by wind power or rain washing alone. Herein, the dust‐induced icing process is clarified, and the process is effectively suppressed by a self‐constraining lubricant (SCL) coating based on ionic liquids (ILs) and zwitterionic copolymers. ILs (EMIES), embedded into the PDMS matrix, enhance the coating's conductivity (≈2.04 S/m) to dissipate surface static electricity and prevent the electrostatic adsorption of charged dust particles. The zwitterionic copolymer in SCL coating is designed to constrain ILs via electrostatic interaction and provide hydrophilic segments to enhance anti‐icing as well as deicing properties (heterogeneous ice nucleation temperature of −27.9°C, icing delay time of 1458 s, and ice adhesion strength of 8.1 kPa). This SCL coating presents dust‐repellent performance and retains excellent anti‐icing properties even when suffering from dust deposition. Meanwhile, it still maintained low ice adhesion strength after 30 icing‐deicing cycles. This work establishes a new dust‐repellent and anti‐icing strategy for outdoor infrastructure.
- 18 July 2025
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 26 (8) , 5119-5129
An Elastin-Like Protein for Injectable Tissue-Like Network
Protein-based tissue fillers are promising for adipose regeneration due to their biocompatibility and tunable properties. Inspired by elastin's structure, we designed a low-immunogenicity "multiple-domain-collective elastin-like" (MDCE) protein for injectable tissue-like networks. The MDCE protein was composed of thermal-responsive elastin-like peptides (disordered domains), polyalanine enrichment (functional ordered domains), and zwitterionic polypeptides (hydrophilic domains). This design endows the MDCE protein hydrogel with in situ injectability and antifouling properties, resulting in a tissue-like modulus-tunable filler formation in vivo without chemical cross-linkers and prevention of foreign body rejection. Adipose stem cells, encapsulated in the MDCE hydrogel, can maintain activity for at least ∼9 days (>80% survival rate). In a rat model of adipose tissue defect, a 3-month injection of MDCE hydrogel for efficiently filling adipose tissue presents superior stability and lower immunogenicity compared to the bovine-source elastin proteins. This work provides methods for tissue fillers and scaffolds, aiding medical regeneration, particularly facial rejuvenation.
- 18 July 2025
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 26 (8) , 5119-5129
An Elastin-Like Protein for Injectable Tissue-Like Network
Protein-based tissue fillers are promising for adipose regeneration due to their biocompatibility and tunable properties. Inspired by elastin's structure, we designed a low-immunogenicity "multiple-domain-collective elastin-like" (MDCE) protein for injectable tissue-like networks. The MDCE protein was composed of thermal-responsive elastin-like peptides (disordered domains), polyalanine enrichment (functional ordered domains), and zwitterionic polypeptides (hydrophilic domains). This design endows the MDCE protein hydrogel with in situ injectability and antifouling properties, resulting in a tissue-like modulus-tunable filler formation in vivo without chemical cross-linkers and prevention of foreign body rejection. Adipose stem cells, encapsulated in the MDCE hydrogel, can maintain activity for at least ∼9 days (>80% survival rate). In a rat model of adipose tissue defect, a 3-month injection of MDCE hydrogel for efficiently filling adipose tissue presents superior stability and lower immunogenicity compared to the bovine-source elastin proteins. This work provides methods for tissue fillers and scaffolds, aiding medical regeneration, particularly facial rejuvenation.
- 15 July 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 288, 117767
Self-healing, degradable, and implantable tissue-like sensor for monitoring of abnormal bladder activity
- 15 July 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 288, 117767
Self-healing, degradable, and implantable tissue-like sensor for monitoring of abnormal bladder activity
- Open Access
- 4 July 2025
- Published by Springer Nature in npj Flexible Electronics
- Vol. 9 (1) , 1-9
Self-healing unmanned aerial vehicle skin for icing prevention and intelligent monitoring
- 4 July 2025
- Published by Springer Nature in npj Flexible Electronics
- Vol. 9 (1) , 1-9
Open AccessSelf-healing unmanned aerial vehicle skin for icing prevention and intelligent monitoring
- 22 May 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (22) , 32054-32065
Low-Concentration Vitrification Agent Based on Polyglutamic Acid and Nanowarming for Porcine Blood Vessel Cryopreservation
Long-term cryopreservation of blood vessels is crucial for cardiovascular disease treatments. To avoid ice crystal-induced injuries and achieve higher recovery, viability, function, and scalability of blood vessels, ice-free vitrification technology is required. However, traditional ice-free vitrification often necessitates high concentrations of toxic cryopreservation agents (CPAs), such as VS55 at concentrations up to 8.4 M. In this study, we successfully achieved low-concentration vitrification using a novel CPA formulation (BTP solution) containing zwitterionic betaine and polyglutamic acid at only 3.6 M. The incorporation of polyglutamic acid significantly enhanced hydration properties, enabling a substantial reduction in the betaine concentration, while enhancing effective vitrification. To achieve uniform rewarming in a large system, gum-acid-coated magnetic nanoparticles were synthesized to facilitate rapid and even rewarming, thereby reducing tissue damage. With this low-concentration BTP, we successfully preserved porcine blood vessels for at least 2 months. After cryopreservation, the vessels retained 92.1% structural integrity, 92.6% biomechanical properties, and normal fiber content and maintained contraction-relaxation capabilities. This low-concentration vitrification technique holds considerable promise for further development and broader application in the cryopreservation of biological tissues and organs.
- 22 May 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (22) , 32054-32065
Low-Concentration Vitrification Agent Based on Polyglutamic Acid and Nanowarming for Porcine Blood Vessel Cryopreservation
Long-term cryopreservation of blood vessels is crucial for cardiovascular disease treatments. To avoid ice crystal-induced injuries and achieve higher recovery, viability, function, and scalability of blood vessels, ice-free vitrification technology is required. However, traditional ice-free vitrification often necessitates high concentrations of toxic cryopreservation agents (CPAs), such as VS55 at concentrations up to 8.4 M. In this study, we successfully achieved low-concentration vitrification using a novel CPA formulation (BTP solution) containing zwitterionic betaine and polyglutamic acid at only 3.6 M. The incorporation of polyglutamic acid significantly enhanced hydration properties, enabling a substantial reduction in the betaine concentration, while enhancing effective vitrification. To achieve uniform rewarming in a large system, gum-acid-coated magnetic nanoparticles were synthesized to facilitate rapid and even rewarming, thereby reducing tissue damage. With this low-concentration BTP, we successfully preserved porcine blood vessels for at least 2 months. After cryopreservation, the vessels retained 92.1% structural integrity, 92.6% biomechanical properties, and normal fiber content and maintained contraction-relaxation capabilities. This low-concentration vitrification technique holds considerable promise for further development and broader application in the cryopreservation of biological tissues and organs.
- 15 May 2025
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 41 (20) , 12664-12674
Mitigating Uricase Immunogenicity through Zwitterionic Peptide Fusion for Enhanced Gout Therapy
Uricase is a promising protein drug for treating gout, but its therapeutic efficacy is significantly limited by its high immunogenicity. In this study, we successfully mitigated the immunogenicity of uricase by fusing zwitterionic peptides (repeated VPKEG sequences) with varying lengths through synthetic biology. The results show that longer zwitterionic peptides can more efficiently improve the enzymatic activity, enhance the substrate affinity, prolong the blood circulation time, and reduce the antibody response. This is likely due to the longer zwitterionic peptides providing a more extensive protective hydration layer, which can shield the immunogenic sites of uricase. As a result, U-(VPKEG)60, the uricase with the longest zwitterionic peptide, significantly enhances therapeutic effects for rat gout models. Moreover, it also exhibits excellent biocompatibility with no hemolysis and negligible cytotoxicity to liver, heart, and kidney functions. Our findings provide new insights into the development of low-immunogenicity uricase through synthetic biology.
- 15 May 2025
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 41 (20) , 12664-12674
Mitigating Uricase Immunogenicity through Zwitterionic Peptide Fusion for Enhanced Gout Therapy
Uricase is a promising protein drug for treating gout, but its therapeutic efficacy is significantly limited by its high immunogenicity. In this study, we successfully mitigated the immunogenicity of uricase by fusing zwitterionic peptides (repeated VPKEG sequences) with varying lengths through synthetic biology. The results show that longer zwitterionic peptides can more efficiently improve the enzymatic activity, enhance the substrate affinity, prolong the blood circulation time, and reduce the antibody response. This is likely due to the longer zwitterionic peptides providing a more extensive protective hydration layer, which can shield the immunogenic sites of uricase. As a result, U-(VPKEG)60, the uricase with the longest zwitterionic peptide, significantly enhances therapeutic effects for rat gout models. Moreover, it also exhibits excellent biocompatibility with no hemolysis and negligible cytotoxicity to liver, heart, and kidney functions. Our findings provide new insights into the development of low-immunogenicity uricase through synthetic biology.
- 13 May 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (21) , 17682-17688
Precise de novo Design Principle of Antifreeze Peptides
De novo design of antifreeze peptides (AFPTs) represents a formidable challenge due to the unclarified active structure of AFPTs. Here, we describe a "Site to Distance" principle for de novo design of AFPTs, in terms of understanding their structure-activity relationships. The first step is to point E, identified as the most potent ice-binding site (IBS) possessing at least 4-fold binding energy than natural IBSs, into the candidate backbones. The second step, based on the IBS (E), is to judiciously adjust the distances of sites to match the favorable number of the ice crystal lattice to achieve the strongest ice-binding, relying on a newly established low-temperature AFPT structure prediction platform. The resultant AFPTs show a substantial reduction in single ice crystal growth rates, much superior to >100 natural or designed AFPTs, including all that have been reported. Cryopreservation of therapeutic cells further confirms the accuracy of this design principle.
- 13 May 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (21) , 17682-17688
Precise de novo Design Principle of Antifreeze Peptides
De novo design of antifreeze peptides (AFPTs) represents a formidable challenge due to the unclarified active structure of AFPTs. Here, we describe a "Site to Distance" principle for de novo design of AFPTs, in terms of understanding their structure-activity relationships. The first step is to point E, identified as the most potent ice-binding site (IBS) possessing at least 4-fold binding energy than natural IBSs, into the candidate backbones. The second step, based on the IBS (E), is to judiciously adjust the distances of sites to match the favorable number of the ice crystal lattice to achieve the strongest ice-binding, relying on a newly established low-temperature AFPT structure prediction platform. The resultant AFPTs show a substantial reduction in single ice crystal growth rates, much superior to >100 natural or designed AFPTs, including all that have been reported. Cryopreservation of therapeutic cells further confirms the accuracy of this design principle.